Ori Biotech partners with Charles River to enhance cell and gene therapy manufacturing using its IRO platform, improving CAR-T outcomes.

Ori Biotech has partnered with Charles River Laboratories to enhance cell and gene therapy manufacturing using Ori's IRO® platform. This collaboration demonstrated that the IRO platform outperformed traditional CAR-T manufacturing methods, achieving higher CAR+ expression and cell yields in a shorter timeframe. The partnership aims to streamline the development process, potentially reducing costs and timelines for bringing therapies to patients.

September 18, 2024
3 Articles